BALCHEM CORP Operating Income Loss

• BALCHEM CORP showed an increase of +14.4% in Operating Income Loss from 2024 to 2025.
• This data is from BALCHEM CORP's annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), BALCHEM CORP's Operating Income Loss has grown by 414.8%.
• Historical annual values: Fiscal year 2025: $209.33 million | Fiscal year 2024: $182.91 million | Fiscal year 2023: $159.19 million | Fiscal year 2022: $145.19 million | Fiscal year 2021: $127.50 million | Fiscal year 2020: $111.15 million | Fiscal year 2019: $102.55 million | Fiscal year 2018: $107.10 million | Fiscal year 2017: $96.90 million | Fiscal year 2016: $90.84 million | Fiscal year 2015: $93.96 million | Fiscal year 2014: $82.14 million | Fiscal year 2013: $65.60 million | Fiscal year 2012: $59.78 million | Fiscal year 2011: $56.23 million | Fiscal year 2010: $49.77 million | Fiscal year 2009: $40.66 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026